Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PARALLEL-GROUP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 68 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Aksoyek, S; Ozer, N; Aytemir, K; Kes, S
      Verapamil SR and trandolapril combination therapy is safe and effective inhypertensive patients with metabolic disorders

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    2. Peuskens, J; De Hert, M; Jones, M
      The clinical value of risperidone and olanzapine: A meta-analysis of efficacy and safety

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    3. McCune, JS; Oertel, MD; Pfeifer, D; Houston, SA; Bingham, A; Sawyer, WT; Lindley, CM
      Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational study

      ANNALS OF PHARMACOTHERAPY
    4. Dranitsaris, G; Leung, P; Warr, D
      Implementing evidence based antiemetic guidelines in the oncology setting:results of a 4-month prospective intervention study

      SUPPORTIVE CARE IN CANCER
    5. Richens, A
      Proof of efficacy trials: cross-over versus parallel-group

      EPILEPSY RESEARCH
    6. Morali, T; Yilmaz, A; Erkan, F; Akkaya, E; Ece, F; Baran, R
      Efficacy of inhaled budesonide and oral theophylline in asthmatic subjects

      JOURNAL OF ASTHMA
    7. Glick, ID; Lemmens, P; Vester-Blokland, E
      Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    8. Kasper, S; Rosillon, D; Duchesne, I
      Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    9. Kasper, S; Jones, M; Duchesne, I
      Risperidone Olanzapine Drug Outcomes studies in Schizophrenia (RODOS): health economic results of an international naturalistic study

      INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
    10. Fleischhacker, WW; Lemmens, P; van Baelen, B
      A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database

      PHARMACOPSYCHIATRY
    11. Rabinowitz, J; Hornik, T; Davidson, M
      Rapid onset of therapeutic effect of risperidone versus haloperidol in a double-blind randomized trial

      JOURNAL OF CLINICAL PSYCHIATRY
    12. Kips, JC; Pauwels, RA
      Low dose inhaled corticosteroids and the prevention of death from asthma

      THORAX
    13. Sharpe, M; Jarvis, B
      Inhaled mometasone furoate - A review of its use in adults and adolescentswith persistent asthma

      DRUGS
    14. de Wit, R; de Boer, AC; von der Linden, GHM; Stoter, G; Sparreboom, A; Verweij, J
      Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy

      BRITISH JOURNAL OF CANCER
    15. Azorin, JM; Spiegel, R; Remington, G; Vanelle, JM; Pere, JJ; Giguere, M; Bourdeix, I
      A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    16. Lader, M
      Rating scales in schizophrenia - A review of their usefulness for assessing atypical antipsychotics

      CNS DRUGS
    17. Bosnjak, SM; Neskovic-Konstantinovic, ZB; Radulovic, SS; Susnjar, S; Mitrovic, LB
      High efficacy of a single oral dose of ondansetron 8 mg versus a metoclopramide regimen in the prevention of acute emesis induced by fluorouracil, doxorubicin and cyclophosphamide (FAC) chemotherapy for breast cancer

      JOURNAL OF CHEMOTHERAPY
    18. Diener, HC; Brune, K; Gerber, WD; Pfaffenrath, V; Straube, A
      Therapy of the acute migraine attack and migraine prophylaxis. Recommendation of the "Deutsche Migrane- und Kopfschmerz-Gesellschaft"

      SCHMERZ
    19. Mohr, E; Mendis, T; Hildebrand, K; De Deyn, PP
      Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial

      MOVEMENT DISORDERS
    20. Diener, HC; Brune, K; Gerber, WD; Pfaffenrath, V; Straube, A
      Therapy of migraine attack and migraine prophylaxis - Recommendations of the German Migraine and Headache Society

      NERVENHEILKUNDE
    21. Diener, HC; Brune, K; Gerber, WD; Pfaffenrath, V; Straube, A
      Therapy of migraine attacks and migraine prophylaxis - Recommendations by the German Society for Migraine and Headache (DMKG)

      AKTUELLE NEUROLOGIE
    22. Mohr, P; Czobor, P
      Subject selection for the placebo- and comparator-controlled trials of neuroleptics in schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    23. Scheuerlein, H; Kube, R; Gastinger, I; Kockerling, F
      Prospective multi-centre comparative study of the treatment of peritonitis. Quality control in the treatment of severe intra-abdominal infections

      ZENTRALBLATT FUR CHIRURGIE
    24. Silberstein, SD; Goadsby, PJ; Lipton, RB
      Management of migraine: An algorithmic approach

      NEUROLOGY
    25. Moller, HJ
      Current assessment of new/atypical neuroleptics

      NERVENARZT
    26. Moller, HJ
      Results and methodological problems in the evaluation of newer atypical neuroleptics in the treatment of schizophrenic negative symptoms

      NERVENARZT
    27. Caton, JG; Ciancio, SG; Blieden, TM; Bradshaw, M; Crout, RJ; Hefti, AF; Massaro, JM; Polson, AM; Thomas, J; Walker, C
      Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis

      JOURNAL OF PERIODONTOLOGY
    28. del Giglio, A; Soares, HP; Caparroz, C; Castro, PC
      Granisetron is equivalent to ondansetron for prophylaxis of chemotherapy-induced nausea and vomiting - Results of a meta-analysis of randomized controlled trials

      CANCER
    29. Taylor, DM; McAskill, R
      Atypical antipsychotics and weight gain - a systematic review

      ACTA PSYCHIATRICA SCANDINAVICA
    30. Remington, G; Kapur, S
      Atypical antipsychotics: are some more atypical than others?

      PSYCHOPHARMACOLOGY
    31. Wallin, A; Sandstrom, T; Soderberg, M; Howarth, P; Lundback, B; Della-Cioppa, G; Wilson, S; Judd, M; Djukanovic, R; Holgate, S; Lindberg, A; Larssen, L
      The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    32. Markowitz, JS; Brown, CS; Moore, TR
      Atypical antipsychotics - Part I: Pharmacology, pharmacokinetics, and efficacy

      ANNALS OF PHARMACOTHERAPY
    33. Moller, HJ
      Atypical neuroleptics: a new approach in the treatment of negative symptoms

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    34. Leucht, S; Pitschel-Walz, G; Abraham, D; Kissling, W
      Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

      SCHIZOPHRENIA RESEARCH
    35. Yan, SY; James, G
      Fast group operations on elliptic curves in maple

      COMPUTERS & MATHEMATICS WITH APPLICATIONS
    36. Lambert, M; Naber, D; Perro, C; Moritz, S; Krausz, M
      Opportunities for new treatments of schizophrenia - Modern antipsychotic medication

      PSYCHIATRISCHE PRAXIS
    37. Peuskens, J; Bech, P; Moller, HJ; Bale, R; Fleurot, O; Rein, W
      Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia

      PSYCHIATRY RESEARCH
    38. Szefler, SJ
      Clinical need for a nebulized corticosteroid

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    39. Lemmens, P; Brecher, M; Van Baelen, B
      A combined analysis of double-blind studies with risperidone vs. placebo and other antipsychotic agents: factors associated with extrapyramidal symptoms

      ACTA PSYCHIATRICA SCANDINAVICA
    40. FOSTER RH; GOA KL
      RISPERIDONE - A PHARMACOECONOMIC REVIEW OF ITS USE IN SCHIZOPHRENIA

      PharmacoEconomics
    41. KRZAKOWSKI M; GRAHAM E; GOEDHALS L; JOLY F; PAWLICKI M; RAPOPORT B; YELLE L; LEES J; MCQUADE B
      A MULTICENTER, DOUBLE-BLIND COMPARISON OF IV AND ORAL-ADMINISTRATION OF ONDANSETRON PLUS DEXAMETHASONE FOR ACUTE CISPLATIN-INDUCED EMESIS

      Anti-cancer drugs
    42. HOES MJAJM
      RECENT DEVELOPMENTS IN THE MANAGEMENT OF PSYCHOSIS

      Pharmacy world & science
    43. CLEOPHAS TJM; DEVOGEL EM
      CROSSOVER STUDIES ARE A BETTER FORMAT FOR COMPARING EQUIVALENT TREATMENTS THAN PARALLEL-GROUP STUDIES

      Pharmacy world & science
    44. KING DJ
      DRUG-TREATMENT OF THE NEGATIVE SYMPTOMS OF SCHIZOPHRENIA

      European neuropsychopharmacology
    45. KING DJ
      QUETIAPINE - RESULTS OF 4 PHASE-II AND PHASE-III CLINICAL-TRIALS

      European psychiatry
    46. ADELROTH E; BARNES NC; CHUNG KF; DAVIES RJ; POULTER LW
      DRUG TRIALS

      The European respiratory journal
    47. ROILA F; BALLATORI E; DEANGELIS V; TONATO M; DELFAVERO A; CICCARESE G; BASURTO C; CICCARESE G; PALLADINO MA; PORROZZI S; PICCIAFUOCO M; CONTU A; OLMEO N; PAZZOLA A; PILO L; TATEO S; CHIAPPARINI I; MORANA S; LUCCHINO S; RICCI S; ANTONUZZO A; ALLEGRINI G; GALLI L; CONTE PF; MASSIDDA B; IONTA MT; SCANU A; MURRU R; PICECE V; CIRILLO M; MAGAROTTO R; NUZZO A; LAUDADIO L; SABLONE MG; LOCATELLI MC; DANTONA A; LUPORINI G; SCAGLIOTTI G; SELVAGGI G; MATTEI A; FAVALLI G; GAMBINO A; FAVA S; GRIMI E; SCARFONE G; BOLIS MC; ALESSANDRONI P; CATALANO G; BONI C; MORETTI G; CORTESI E; MARTELLI O; ANTIMI M; BELLINI V; BUZZI E; BRUGIA M; GRECCHI M; CLERICO M; MONTINARI F; DONATI D; SANSONI E
      DOUBLE-BLIND, DOSE-FINDING STUDY OF 4 INTRAVENOUS DOSES OF DEXAMETHASONE IN THE PREVENTION OF CISPLATIN-INDUCED ACUTE EMESIS

      Journal of clinical oncology
    48. MOLLER HJ; GAGIANO CA; ADDINGTON DE; VONKNORRING L; TORRESPLANK JF; GAUSSARES C
      LONG-TERM TREATMENT OF CHRONIC-SCHIZOPHRENIA WITH RISPERIDONE - AN OPEN-LABEL, MULTICENTER STUDY OF 386 PATIENTS

      International clinical psychopharmacology
    49. ZITO JM
      PHARMACOECONOMICS OF THE NEW ANTIPSYCHOTICS FOR THE TREATMENT OF SCHIZOPHRENIA

      The Psychiatric clinics of North America
    50. MELTZER HY; CASEY DE; GARVER DL; LASAGNA L; MARDER SR; MASAND PS; MILLER D; PICKAR D; TANDON R
      CLINICAL DEVELOPMENT OF ATYPICAL ANTIPSYCHOTICS - RESEARCH DESIGN ANDEVALUATION

      The Journal of clinical psychiatry
    51. PEREZ EA
      A RISK-BENEFIT ASSESSMENT OF SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS IN ANTINEOPLASTIC THERAPY-INDUCED EMESIS

      Drug safety
    52. GREGORY RE; ETTINGER DS
      5-HT3 RECEPTOR ANTAGONISTS FOR THE PREVENTION OF CHEMOTHERAPY-INDUCEDNAUSEA AND VOMITING - A COMPARISON OF THEIR PHARMACOLOGY AND CLINICALEFFICACY

      Drugs
    53. HUC P; BLOCK S; CARLIER D; DARLOY F; BONNETERRE ME; BLEUSE JP; FOURNIER C; BONNETERRE J
      ORAL GRANISETRON VERSUS ORAL ONDANSETRON FOR THE PREVENTION OF NAUSEAVOMITING INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPIES

      Bulletin du cancer
    54. POON RTP; CHOW LWC
      COMPARISON OF ANTIEMETIC EFFICACY OF GRANISETRON AND ONDANSETRON IN ORIENTAL PATIENTS - A RANDOMIZED CROSSOVER STUDY

      British Journal of Cancer
    55. BONDOLFI G; DUFOUR H; PATRIS M; MAY JP; BILLETER U; EAP CB; BAUMANN P
      RISPERIDONE VERSUS CLOZAPINE IN TREATMENT-RESISTANT CHRONIC-SCHIZOPHRENIA - A RANDOMIZED DOUBLE-BLIND-STUDY

      The American journal of psychiatry
    56. VIALE G; MECHLING L; MAISLIN G; DURKIN M; ENGELHART L; LAWRENCE BJ
      IMPACT OF RISPERIDONE ON THE USE OF MENTAL-HEALTH-CARE RESOURCES

      Psychiatric services
    57. ROILA F; BALLATORI E; TONATO M; DELFAVERO A
      5-HT3 RECEPTOR ANTAGONISTS - DIFFERENCES AND SIMILARITIES

      European journal of cancer
    58. WARR D
      STANDARD TREATMENT OF CHEMOTHERAPY-INDUCED EMESIS

      Supportive care in cancer
    59. LOFTERS WS; PATER JL; ZEE B; DEMPSEY E; WALDE D; MOQUIN JP; WILSON K; HOSKINS P; GUEVIN RM; VERMAN S; NAVARI R; KROOK JE; HAINSWORTH J; PALMER M; CHIN C
      PHASE-III DOUBLE-BLIND COMPARISON OF DOLASETRON MESYLATE AND ONDANSETRON AND AN EVALUATION OF THE ADDITIVE ROLE OF DEXAMETHASONE IN THE PREVENTION OF ACUTE AND DELAYED NAUSEA AND VOMITING DUE TO MODERATELY EMETOGENIC CHEMOTHERAPY

      Journal of clinical oncology
    60. BRUGGENJURGEN B; DUBOIS A
      COST-EFFICACY OF 5-HT3-RECEPTOR ANTAGONIS TS IN THE TREATMENT OF ACUTE CHEMOTHERAPY-INDUCED EMESIS - HEALTH ECONOMIC-ANALYSIS BASED ON RECENT METAANALYTIC RESULTS

      Medizinische Klinik
    61. MATTES JA
      RISPERIDONE - HOW GOOD IS THE EVIDENCE FOR EFFICACY

      Schizophrenia bulletin
    62. SCHNITZER TJ; CONSTANTINE G
      ETODOLAC (LODINE(R)) IN THE TREATMENT OF OSTEOARTHRITIS - RECENT STUDIES

      Journal of rheumatology
    63. SONG FJ
      RISPERIDONE IN THE TREATMENT OF SCHIZOPHRENIA - A METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS

      JOURNAL OF PSYCHOPHARMACOLOGY
    64. PECTASIDES D; MYLONAKIS A; VARTHALITIS J; KOSTOPOULOU M; CONSTANTINOU A; PAPAZACHARIOU K; ANTONIOU F; DIMITRIADIS M; ATHANASSIOU A
      COMPARISON OF 2 DIFFERENT DOSES OF ONDANSETRON PLUS DEXAMETHASONE IN THE PROPHYLAXIS OF CISPLATIN-INDUCED EMESIS

      Oncology
    65. CLEOPHAS TJM; VANDERMEY N; VANDERMEULEN J; NIEMEYER MG
      QUALITY-OF-LIFE BEFORE AND DURING ANTIHYPERTENSIVE TREATMENT - A COMPARATIVE-STUDY OF CELIPROLOL AND ATENOLOL

      International journal of clinical pharmacology and therapeutics
    66. ROILA F; TONATO M; BALLATORI E; DELFAVERO A
      COMPARATIVE-STUDIES OF VARIOUS ANTIEMETIC REGIMENS

      Supportive care in cancer
    67. CLEOPHAS TJM
      CLINICAL-TRIALS - RELEVANCE OF CORRELATION BETWEEN TREATMENT RESPONSES

      European Journal of Clinical Pharmacology
    68. CLEOPHAS TJM
      CLINICAL-TRIALS - RELEVANCE OF CORRELATION BETWEEN TREATMENT MODALITIES

      International journal of clinical pharmacology and therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 15:18:55